Bowling Vaccine & Pharmaceutical Inc - CA San Francisco, San Francisco 94122

Bowling Vaccine & Pharmaceutical Inc entered the industry of Biological Research in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of $2.500.000 to $4.999.999. The NAICS classifies this business under the code 541712, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.

To acquire more information, please contact Steven J Dunn by calling (415) 731-8649 during business hours. You can also write to the business’ Single Location at 1631 45th Avenue, San Francisco, California CA 94122. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Bowling Vaccine & Pharmaceutical Inc
Representative: Steven J Dunn
Place of Business: 1631 45th Avenue, San Francisco, CA 94122
Contact Number: (415) 731-8649
Type of Service: Biological Research
SIC Number: 8731
NAICS Number: 541712
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2002
Income/Year: $2.500.000 to $4.999.999
Laborers: 1 to 4
Share This Company:

Bowling Vaccine & Pharmaceutical Inc is a company operating from San Francisco, California providing professional Biological Research and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 541712 as Biological Research.

With a current employee count of 1 to 4, Bowling Vaccine & Pharmaceutical Inc has gone to report making $2.500.000 to $4.999.999 per annum on its journey towards growth. This company invites you to contact its representative Steven J Dunn at (415) 731-8649 for related queries, or to locate its Single Location using the coordinates 37.756127,-122.504738.

The Single Location can also be found at the street address 1631 45th Avenue in San Francisco, California 94122 and can be engaged online through the company website at , the company Twitter , and Facebook page .